Research & Development

Regeneron to develop antibodies for novel coronavirus with HHS support

Regeneron Pharmaceuticals has expanded its collaboration with the US Department of Health and Human Services (HHS) to develop antibody treatments for novel coronavirus (2019-nCoV).

Bristol-Myers Squibb, BioMotiv launch new biotechnology firm Anteros Pharmaceuticals

Bristol-Myers Squibb (BMS) and BioMotiv have launched a new biotechnology company, Anteros Pharmaceuticals, which will involve in the development of a new class of drugs for fibrotic and other inflammatory diseases.

Catalent to buy cell and gene therapy CDMO MaSTherCell for $315m

US-based Catalent has agreed to acquire cell therapy company MaSTherCell Global for $315m in cash.

GSK partners with CEPI to develop vaccine for novel Coronavirus

British drugmaker GlaxoSmithKline (GSK) has collaborated with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine for the novel Coronavirus (2019-nCoV).

Johnson & Johnson launches multi-pronged response to coronavirus global public health threat

Johnson & Johnson announced that it is mobilizing resources at its Janssen Pharmaceutical Companies to launch a multi-pronged response to the novel coronavirus (also known as 2019-nCoV or Wuhan coronavirus) outbreak.

Accenture selects Google Cloud as cloud technology provider for INTIENT

Accenture has entered into a technology collaboration with Google Cloud with an objective to help life sciences companies advance the discovery, development, and delivery of their innovative therapies.

Alexion wraps up $930m acquisition of Achillion

Alexion Pharmaceuticals has completed the acquisition of clinical-stage biopharmaceutical company Achillion Pharmaceuticals for around $930m.

HighRes Biosolutions and Novo Nordisk partner to transform drug discovery in automated lab of future

HighRes Biosolutions and Novo Nordisk announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation.

US reports first case of novel coronavirus from China-returned traveller

The US Centers for Disease Control and Prevention (CDC) has reported the first case of 2019 Novel Coronavirus (2019-nCoV) in the US state of Washington following the return of a patient from China who tested positive to the virus.